By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



793 Darby Paoli Road

Bryn Mawr  Pennsylvania  19010-1145  U.S.A.
Phone: 610-800-2443 Fax: n/a



Company News
Oncoceutics Begins ONC201 Endometrial Cancer Trial; Receives NIH Grant 9/13/2017 10:13:38 AM
Oncoceutics Release: ONC201 Trial For Neuroendocrine Cancer Begins At Cleveland Clinic 8/14/2017 2:41:39 PM
Oncoceutics Release: Mechanistic Study Uncovers New Utility Of ONC201 Mechanism In Lymphoma 7/14/2017 7:23:56 AM
Oncoceutics Extends Patent Family To Include ONC201 In Leukemias 7/11/2017 7:26:35 AM
Oncoceutics Release: Cell Cycle Article Describes Anti-Cancer Efficacy Of Imipridones 6/14/2017 1:27:55 PM
Oncoceutics Release: Efficacy Results For ONC201 In Recurrent Glioblastoma Published 5/31/2017 1:24:23 PM
Oncoceutics Release: Research Publications Provide Rationale For ONC201 Trials In Breast Cancer 5/9/2017 10:41:06 AM
Oncoceutics Release: Fox Chase Cancer Center Enrolling Patients In ONC201 Multiple Myeloma Trial 5/1/2017 10:02:06 AM
Oncoceutics Presentations On ONC201 And Other Imipridones At AACR 2017 3/28/2017 10:22:08 AM
Oncoceutics Release: ONC201 Phase I Trial Results Reported In Clinical Cancer Research 3/28/2017 10:18:56 AM